Exposure to cigarette smoke does not decrease the neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice
暂无分享,去创建一个
[1] H. Freimuth,et al. Carbon Monoxide in Blood: a Simple and Rapid Estimation , 1943 .
[2] E. Diamond,et al. Epidemiologic studies of Parkinson's disease. I. Smoking and Parkinson's disease: a survey and explanatory hypothesis. , 1971, American journal of epidemiology.
[3] R. Heikkila. Differential neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in Swiss-Webster mice from different sources. , 1985, European journal of pharmacology.
[4] R. Godwin-Austen,et al. Smoking and Parkinson's disease. , 1982, Journal of neurology, neurosurgery, and psychiatry.
[5] D. Godin,et al. Parkinson's disease: A disorder due to nigral glutathione deficiency? , 1982, Neuroscience Letters.
[6] R. Marttila,et al. Smoking and Parkinson's disease , 1980, Acta neurologica Scandinavica.
[7] R. Clavier,et al. Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouse , 1985, Neuroscience Letters.
[8] M. Nefzger,et al. A retrospective study of smoking in Parkinson's disease. , 1968, American journal of epidemiology.
[9] I. I. Kessler,et al. EPIDEMIOLOGIC STUDIES OF PARKINSON'S DISEASE: III. A COMMUNITY-BASED SURVEY , 1972 .
[10] L. Golbe,et al. Smoking and Parkinson's disease. Search for a dose-response relationship. , 1986, Archives of neurology.
[11] R. Baumann,et al. Cigarette smoking and Parkinson disease , 1980, Neurology.
[12] K. Jellinger,et al. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. , 1973, Journal of the neurological sciences.
[13] S J Kish,et al. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) does not destroy nigrostriatal neurons in the scorbutic guinea pig. , 1985, Life sciences.
[14] J. Langston,et al. MPTP and parkinson's disease , 1985, Trends in Neurosciences.